𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease

✍ Scribed by Huijuan Li; Meifen Zhang; Ling Chen; June Zhang; Zhong Pei; Ailing Hu; Qing Wang


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
83 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We performed a cross‐sectional study of 82 Chinese patients with Parkinson's disease (PD) enrolled during an 18‐month period using a clinical interview to assess the prevalence of nonmotor symptoms (NMS), the association with disease severity and motor status, and the impact on patients' health‐related quality of life (Hr‐QoL). The patients' NMS, Hr‐QoL, disease severity, and motor status were assessed by the Nonmotor Symptoms Scale (NMSS), the 39‐item Parkinson's Disease Questionnaire (PDQ‐39), the modified Hoehn and Yahr staging scale (H&Y) and the Unified Parkinson's Disease Rating Scale part III (UPDRS III), respectively. We found that 100% of patients with PD presented with NMS. The NMSS significantly correlated with disease duration (Spearman's r~S~ = 0.276, P = 0.012), H&Y (r~S~ = 0.230, P = 0.038), and UPDRS III (r~S~ = 0.350, P = 0.001). Similarly, the PDQ‐39 SI significantly associated with the disease duration (r~S~ = 0.258, P = 0.019), H&Y (r~S~ = 0.340, P = 0.002), and UPDRS III (r~S~ = 0.453, P < 0.001). NMS domains that influenced the PDQ‐39 SI were sleep/fatigue, mood, gastrointestinal, urinary, and miscellaneous symptoms. This strongly suggested that the five domains played a key role in the manifestation of Hr‐QoL. NMSS explains more of the variability in Hr‐QoL than UPDRS III, when both are the model (stepwise multiple linear regression analysis R^2^ change, 47.8% vs. 5.87%, respectively). Therefore, these findings demonstrate that NMS are independently and negatively associated with Hr‐QoL in PD and that improving NMS should be viewed as an important part in the management of PD. © 2010 Movement Disorder Society


📜 SIMILAR VOLUMES


Health-Related quality of life in patien
✍ Helle Just; Karen Ostergaard 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Parkinson's disease (PD) is a progressive neurodegenerative disorder for which there is as yet no cure. It affects many aspects of patients' lives, only some of which can be monitored by available clinical rating scales. In the past decade, there has been a new emphasis on the use of health-related

Sustained improvement of health-related
✍ Francesc Casellas; Luis Rodrigo; Pilar Niño; Carmen Pantiga; Sabino Riestra; Jua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

## Background: Infliximab induces remission and improves the health-related quality of life (hrqol) of patients with refractory or fistulous crohn's disease (cd). however, little information is available as to whether its effect on hrqol is sustained over time. the objective was to measure the hrqo

The INSPIRE study: Are different persona
✍ Birgitte Boye; Jorgen Jahnsen; Kjell Mokleby; Siv Leganger; Günter Jantschek; In 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## Background: To explore the relationship between personality and disease-specific quality of life [Inflammatory Bowel Disease Questionnaire (IBDQ)] in distressed [Perceived Stress Questionnaire (PSQ)] patients with ulcerative colitis (UC) and Crohn's disease (CD). Methods: Included in the study

Impact of oral cyclophosphamide on healt
✍ Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC